751 related articles for article (PubMed ID: 30640748)
21. Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders.
Ter-Stepanian M; Grizenko N; Zappitelli M; Joober R
Can J Psychiatry; 2010 May; 55(5):305-12. PubMed ID: 20482957
[TBL] [Abstract][Full Text] [Related]
22. Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.
Tzang RF; Chang YC; Tsai GE; Lane HY
J Psychopharmacol; 2016 Oct; 30(10):976-82. PubMed ID: 27443598
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
Kaplan S; Heiligenstein J; West S; Busner J; Harder D; Dittmann R; Casat C; Wernicke JF
J Atten Disord; 2004 Oct; 8(2):45-52. PubMed ID: 15801334
[TBL] [Abstract][Full Text] [Related]
24. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.
Goez H; Back-Bennet O; Zelnik N
J Child Neurol; 2007 May; 22(5):538-42. PubMed ID: 17690058
[TBL] [Abstract][Full Text] [Related]
25. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
Biederman J; Spencer TJ; Newcorn JH; Gao H; Milton DR; Feldman PD; Witte MM
Psychopharmacology (Berl); 2007 Jan; 190(1):31-41. PubMed ID: 17093981
[TBL] [Abstract][Full Text] [Related]
26. Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder.
Kim JI; Kim JW; Park JE; Park S; Hong SB; Han DH; Cheong JH; Choi JW; Lee S; Kim BN
J Psychopharmacol; 2017 Aug; 31(8):1070-1077. PubMed ID: 27624150
[TBL] [Abstract][Full Text] [Related]
27. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
29. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
Gadow KD; Nolan EE; Sverd J; Sprafkin J; Schneider J
J Child Neurol; 2008 Sep; 23(9):981-90. PubMed ID: 18474932
[TBL] [Abstract][Full Text] [Related]
30. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
31. An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.
Zheng Y; Liang JM; Gao HY; Yang ZW; Jia FJ; Liang YZ; Fang F; Li R; Xie SN; Zhuo JM
Chin Med J (Engl); 2015 Nov; 128(22):2988-97. PubMed ID: 26608976
[TBL] [Abstract][Full Text] [Related]
32. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
34. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
35. How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.
van Wyk GW; Hazell PL; Kohn MR; Granger RE; Walton RJ
J Atten Disord; 2012 May; 16(4):314-24. PubMed ID: 21289234
[TBL] [Abstract][Full Text] [Related]
36. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
[TBL] [Abstract][Full Text] [Related]
37. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
38. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
39. [An open trial on effectiveness of parent training in children with comorbid attention deficit hyperactivity disorder and oppositional defiant disorder].
Liu J; Wang YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):310-4. PubMed ID: 17572790
[TBL] [Abstract][Full Text] [Related]
40. Oppositional defiant disorder in adults with ADHD.
Reimherr FW; Marchant BK; Olsen JL; Wender PH; Robison RJ
J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]